Leadership Transition at Tecan Signals New Beginnings
Männedorf, Switzerland – Tecan Group (SIX Swiss Exchange: TECN) has embarked on an important leadership transition, marking a significant moment in its journey of growth. After serving as CEO for over six years, Dr. Achim von Leoprechting will officially step down on August 1, 2025. His decision to move on is coupled with a commitment to ensure continuity and stability during this important change.
Introducing Monica Manotas as the New CEO
As Tecan shapes its future, the Board of Directors has announced the appointment of Monica Manotas, a valued Board member since April 2024, as the new CEO. Starting her role on August 1, 2025, Ms. Manotas comes with a wealth of international experience, having dedicated over 20 years to key roles in the life sciences industry, prominently with Thermo Fisher Scientific. This rich background equips her well to lead Tecan into its next exhilarating chapter.
Working Together for a Smooth Transition
A seamless transition is vital for any organization, and Tecan is well aware of this. Dr. von Leoprechting and Ms. Manotas will collaborate closely to ensure that the shift of leadership is smooth and effective. Each brings crucial insights and knowledge that will aid in steering Tecan towards continued success.
Financial Outlook and Company Performance
Keeping investors informed, Tecan plans to release its financial results for the first half of 2025 on August 12, 2025. It has communicated that sales may decline in the mid-single-digit percentage range in local currencies during this period, while confirming its 2025 outlook remains optimistic. Such transparency is a testament to Tecan’s commitment to shareholders and the market.
Reflecting on Achievements
In a recent statement, Dr. Lukas Braunschweiler, the Chairman of the Board, praised Dr. von Leoprechting’s leadership, noting that Tecan has grown significantly under his guidance, achieving a remarkable 60% growth since 2018. This growth has been supported by a mix of organic expansion and strategic acquisitions, all the while maintaining healthy EBITDA margins.
Monica Manotas: Vision for Future Growth
Monica Manotas expressed her enthusiasm for the new role, emphasizing her dedication to fostering innovation and enhancing customer engagement at Tecan. Having deep insights gleaned from her time on the Board, she recognizes the importance of agility and a customer-centered approach in the life sciences sector. Her leadership will prioritize not just sustaining current operations but also seizing emerging opportunities.
A Look at Tecan’s Legacy and Future
Tecan is renowned internationally as a pioneer in laboratory automation and is crucial in providing solutions that enhance healthcare innovation. Founded in 1980, the company has established itself as a leader in developing OEM instruments and devices. With a robust workforce exceeding 3,000 employees and a vast reach across more than 70 countries, Tecan’s footprint in the life sciences sector is both significant and impactful.
About Tecan's New Leadership
Before joining Tecan, Monica Manotas held significant roles at Thermo Fisher Scientific, contributing extensively to various international projects across Europe, the USA, and other locations. Holding degrees in industrial engineering and an MBA in Finance, her diverse experience promises to be a great asset to Tecan as it navigates future challenges and opportunities.
Frequently Asked Questions
What prompted the leadership change at Tecan?
Dr. Achim von Leoprechting decided to transition due to personal reasons while ensuring a smooth handover to Monica Manotas.
Who is the new CEO of Tecan?
Monica Manotas, currently a Board member, has been appointed the new CEO and will assume the role on August 1, 2025.
What is Tecan's business focus?
Tecan specializes in laboratory automation, creating innovative solutions to enhance healthcare and life sciences research.
What changes are expected under the new CEO?
Monica Manotas plans to continue driving innovation and a customer-centric approach while leveraging her international experience.
When will Tecan report its financial results?
Tecan is set to publish its financial results for the first half of 2025 on August 12, 2025.
